The Health Care Policy Blog is a forum for health care policy professionals and Bloomberg BNA editors to share ideas, raise issues, and network with colleagues.
Wednesday, July 17, 2013
by James Swann
GAO recommended CMS require that providers indicate whether biopsy services were self-referred or not, and also called on the agency to devise a new payment structure to remove the financial incentive linked to self-referral.
The report was prepared for for Sens. Max Baucus (D-Mont.) and Chuck Grassley (R-Iowa) and Reps. Henry A. Waxman (D-Calif.) and Sander M. Levin (D-Mich.), and Baucus and Grassley each said that CMS should focus on ensuring that biopsy services are in a patient's best interest, and not being performed for financial gain. "Federal policy should drive doctors to make decisions based on quality of care, not financial relationships," Grassley said.
You must Sign In or Register to post a comment.
Congressional Budget Impasse Threatens Medicare Doc Fix, Lobbyist Says
Stark Self-Disclosures Are on the Rise
Providers Increasingly Self-Disclosing Overpayments
Medicare Appeal Success Rates Trending Down
Senate Finance Committee to Look at Health Insurance Exchanges